The Association of Healthcare Internal Auditors (AHIA) 38th Annual Conference, “Harmonizing the Complexities of Healthcare Internal Auditing,” will take place September 15-18, 2019, in Nashville, TN. The event offers healthcare professionals growth and development opportunities on a variety of emerging topics. A host of PYA thought leaders are among those on the agenda to discuss industry changes.
PYA Principal Tynan Kugler and Consulting Manager Susan Thomas will present “Auditing Healthcare Focus Arrangements for Regulatory Compliance: Physicians, Management Services, Post-Discharge Care, Ambulance Services, and Specialty Care.” In their presentation, they will:
- Describe what constitutes a focus arrangement for healthcare organizations.
- Explain the implications of Stark Law and Anti-Kickback violations, along with Corporate Integrity Agreement focus arrangement requirements.
- Discuss essential focus arrangement procedures to facilitate regulatory compliance.
- Provide an example design of an audit plan approach for focus arrangements.
PYA Tampa Office Managing Principal Angie Caldwell and Consulting Senior Manager Sarah Bowman will address “The Opioid Epidemic: An Important Auditor Update” in their presentation. They will:
- Provide an overview of the scope of the opioid crisis, emerging trends in opioid abuse, and recent regulatory activity.
- Analyze key internal control risk areas to prevent drug diversion.
- Review specific examples of monitoring for fraud and abuse related to the opioid epidemic.
PYA Principal Barry Mathis will present “The IT Analysis Paralysis,” in which attendees will:
- Receive a compressive review of the many IT frameworks that can be used to develop effective internal audit programs.
- Learn the differences between commercial, federal, and industry frameworks.
- Receive tips, tools, and techniques for creating an effective framework based on risk assessment and identified risks.
PYA Consulting Seniors Jennifer Bridgeforth and Jennifer Kastner will also present “The Current Regulatory Environment and Auditing Urine Drug Testing.” Attendees will:
- Learn the history of urine drug test (UDT) billing changes.
- Understand current requirements of UDT coding and documentation.
- Learn common compliance issues.
- Become familiar with best practice recommendations.
Learn more and register here.
If you would like more information about focus arrangements, monitoring for fraud and abuse related to the opioid crisis, or the current regulatory and auditing environment for UDT, or would like assistance with any matter involving healthcare audit or compliance, contact one of our PYA executives below at (800) 270-9629.